Delivery Order SPE2DB22D2206-SPE2DB25FHF08
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $2,174.90 to supply 100 tablets of Nucynta 50 mg, a prescription opioid pain medication. This non-set-aside, competitively awarded contract was executed on August 22, 2025, with an ultimate completion date of August 25, 2025, and reflects a firm fixed-price arrangement. The order is being fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.04 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 50 mg, a prescription opioid medication used for pain management. This competitively awarded, firm fixed-price delivery order was finalized on May 30, 2025, with an ultimate completion date of June 2, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,979.28 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 100 mg, a prescription opioid pain medication. This non-set-aside, competitively awarded delivery order reflects firm fixed pricing and was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 100 mg, a prescription opioid medication used for pain management. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 15, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,531.10 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 150 mg, a prescription opioid pain management medication. The award, made on May 20, 2025, with completion targeted for May 21, 2025, utilized firm fixed price contracting with no set-aside designation, indicating competitive award procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,810.39 for 60-count tablets of Nucynta ER 50 mg, an opioid pain management medication. Issued on September 4, 2025, with an ultimate completion date of September 5, 2025, this firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,013.96 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 150 mg, an extended-release opioid pain medication. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 25, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a $3,580.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 75 mg, a prescription opioid pain management medication. The contract, awarded on September 18, 2025, with completion targeted for September 19, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This award was not designated as a set-aside and was competitively...
- The Defense Logistics Agency awarded a $2,928.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 200 mg, a prescription opioid pain management medication. The contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 200 mg, a prescription opioid pain management medication, with a contract ceiling value of $2,411.52. This is a firm fixed-price delivery order issued on August 6, 2025, with an ultimate completion date of August 7, 2025, with no set-aside designation. The place of performance is the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHF08Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,225.04 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 50 mg, a prescription opioid pain medication. The contract, which is a child order under a larger indefinite delivery vehicle, was competitively awarded without set-aside provisions and carries a firm fixed price structure. The delivery order was awarded on May 30, 2025, with an ultimate completion date of June 2, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor providing a broad range of medications, vaccines, medical devices, and healthcare commodities to federal medical procurement needs, particularly for military and veteran healthcare systems. The company's contract portfolio with DLA demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 5/30/25 |